PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
Clinical trial NCT06074692 · RECRUITING
Trial details
- NCT number
- NCT06074692
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2026-08-30
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.